Authors
Loading...
Oral administration of CKDB-322 reduces body weight and serum lipids in high-fat-diet-induced obese mice, suggesting potential for dietary obesity management.
Noh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: